SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-011211
Filing Date
2021-05-13
Accepted
2021-05-13 08:21:38
Documents
13
Period of Report
2021-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39234
2 ex99-1.htm EX-99.1 60494
  Complete submission text file 0001493152-21-011211.txt   282916

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE crbp-20210513.xsd EX-101.SCH 3035
4 XBRL LABEL FILE crbp-20210513_lab.xml EX-101.LAB 34914
5 XBRL PRESENTATION FILE crbp-20210513_pre.xml EX-101.PRE 22795
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3673
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 21917323
SIC: 2834 Pharmaceutical Preparations